Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 936 shares at $50.86 ($48K) on 2016-12-20, disclosed to the SEC on 2016-12-22.
Open-market sale of $48k KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |